Results 231 to 240 of about 15,549,143 (355)
Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor Agonists
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‑1 RAs) play a pivotal role in treating type 2 diabetes. Despite their widespread use, their dermatological manifestations remain under‐recognized, hence the interest of this systematic review. Objectives This systematic review aims to assess dermatological manifestations associated with
Nour Ghostine, Maya Halabi‐Tawil
wiley +1 more source
Diabetes duration, glycemic control, and risk of stroke and stroke subtypes: a nationwide prospective cohort study. [PDF]
Gao X +9 more
europepmc +1 more source
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang +7 more
wiley +1 more source
Carbohydrate Counting as a Precision Method for Glycemic Control in Youth With Type 1 Diabetes: A Systematic Review and Meta-Analysis. [PDF]
Guarçoni PV +3 more
europepmc +1 more source
Lysosome Evanescence Mediates Autophagic Flux Impairment in Glucose Imbalanced Environments
ABSTRACT Schwann cells (SCs) support axonal function and promote nerve regeneration. This study investigated how various glucose concentrations influence SC viability, oxidative stress, and autophagy, which contribute to diabetic neuropathy. RSC96 SCs were cultured under five glucose conditions (0, 2.5, 5.5, 50, or 100 mM) for 24, 48, and 72 h.
Yuan‐Chen Cheng +6 more
wiley +1 more source
Optimal exercise dose for glycemic control in prediabetes across different exercise types. [PDF]
Yan R +7 more
europepmc +1 more source

